DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Otros (Other)
Design of Novel Vaccines Based on Virus-Like Particles
Virus-like particles (VLPs) are formed by viral proteins that, when overexpressed, spontaneously self-assemble into particles that structurally are similar to infectious virus or subviral particles (e.g. the viral capsid). VLPs are appealing as vaccine candidates because their inherent properties (i.e. virus-sized, multimeric antigens, highly organised and repetitive structure, not infectious) are suitable for the induction of safe and efficient humoral and cellular immune responses. VLP-based vaccines have already been licensed for human and veterinary use, and many more vaccine candidates are currently in late stages of evaluation. Moreover, the development of VLPs as platforms for foreign antigen display has further broadened their potential applicability both as prophylactic and therapeutic vaccines. This chapter provides an overview on the design and use of VLPs for the development of new-generation vaccines., Their work is funded by grants from the Spanish Ministry of Science and Innovation (PID2019-107145RB-I00 and PID2022-140925OB-I00); Comunidad de Madrid co-financed with ECFEDER funds (S2018/BAA-4370 PLATESA 2) and European Union’s Horizon 2020 Research and Innovation Programme (VetBioNet, grant agreement No. 731014 and LAGMED, PRIMA S2–11-PCI2019–103732)., Peer reviewed
Proyecto:
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PID2019-107145RB-I00
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2022-140925OB-I00
,
EC / H2020 731014
DOI: http://hdl.handle.net/10261/395668, https://api.elsevier.com/content/abstract/scopus_id/85214325017
HANDLE: http://hdl.handle.net/10261/395668, https://api.elsevier.com/content/abstract/scopus_id/85214325017